Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMan Regulatory News (EMG)

Share Price Information for Man (EMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 249.80
Bid: 249.60
Ask: 250.00
Change: -5.80 (-2.27%)
Spread: 0.40 (0.16%)
Open: 252.60
High: 254.60
Low: 249.80
Prev. Close: 255.60
EMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report

11 Mar 2022 10:05

RNS Number : 5029E
Man Group plc
11 March 2022
 

Man Group plc (the "Company")

In compliance with Listing Rule 9.6.1 the following documents have been submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

1. Annual Report for the year ended 31 December 2021 (the "Annual Report")

2. Notice of the 2022 Annual General Meeting (the "AGM Notice")

3. Form of Proxy for the 2022 Annual General Meeting

4. Amended rules of the Man Group 2019 Sharesave Scheme (the "Sharesave Rules") to be presented to shareholders at the 2022 Annual General Meeting

The Annual Report, AGM Notice and Sharesave Rules are also available on the Company's website at www.man.com.

The Company confirms that, in compliance with DTR 6.3.5(1A), the regulated information required under DTR 6.3.5, is available in unedited full text within the Annual Report available on the National Storage Mechanism and on the Company's website as noted above.

 

Enquiries

 

Georgiana Brunner

Head of Communications

+44 (0)20 7144 1239

media@man.com 

 

Karan Shirgaokar

Director, Investor Relations

+44 (0)20 7144 1434

investor.relations@man.com 

 

Elizabeth Woods

Company Secretary

+44 (0)20 7144 1733

company.secretarial@man.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSGCGDXRUBDGDB
Date   Source Headline
3rd Sep 20217:02 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
2nd Sep 20215:56 pmRNSTransaction in Own Shares
2nd Sep 20216:59 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
2nd Sep 20216:48 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
1st Sep 20215:54 pmRNSTransaction in Own Shares
1st Sep 20217:21 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
1st Sep 20217:06 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
1st Sep 20217:00 amRNSTotal Voting Rights
31st Aug 20216:02 pmRNSTransaction in Own Shares
31st Aug 20217:47 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
31st Aug 20217:22 amGNWMan Group PLC : Form 8.3 - Stonebridge Biopharma plc
30th Aug 20217:22 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
27th Aug 20215:41 pmRNSTransaction in Own Shares
27th Aug 20218:20 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
26th Aug 20215:35 pmRNSTransaction in Own Shares
26th Aug 202110:18 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
25th Aug 20215:47 pmRNSTransaction in Own Shares
25th Aug 202112:59 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
25th Aug 202112:54 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
24th Aug 20215:45 pmRNSTransaction in Own Shares
24th Aug 202112:21 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
24th Aug 202112:17 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
23rd Aug 20216:24 pmRNSTransaction in Own Shares
23rd Aug 20211:49 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
23rd Aug 20211:47 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
20th Aug 20215:53 pmRNSTransaction in Own Shares
20th Aug 20218:57 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
20th Aug 20218:56 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
19th Aug 20215:55 pmRNSTransaction in Own Shares
19th Aug 202112:27 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
19th Aug 202112:23 pmGNWMan Group PLC : Form 8.3 - Vectura Group plc
19th Aug 20219:00 amRNSInterim Dividend Conversion Rate
18th Aug 20215:25 pmRNSTransaction in Own Shares
18th Aug 20218:24 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
17th Aug 20216:03 pmRNSTransaction in Own Shares
17th Aug 202110:24 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
16th Aug 20215:59 pmRNSTransaction in Own Shares
16th Aug 202112:05 pmGNWMan Group PLC : Form 8.3 - Strongbridge biopharma plc
13th Aug 20215:20 pmRNSTransaction in Own Shares
13th Aug 202111:05 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
12th Aug 20215:57 pmRNSTransaction in Own Shares
12th Aug 202111:23 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
11th Aug 20215:45 pmRNSTransaction in Own Shares
11th Aug 202110:36 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
11th Aug 20217:00 amRNSTransaction in Own Shares
10th Aug 202111:59 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
10th Aug 20217:00 amRNSShare buyback programme of up to $100 million
9th Aug 20219:41 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
9th Aug 20219:39 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
6th Aug 20219:59 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.